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We examined the associations of body mass index (BMI), waist circumference, a history of diabetes, and cigarette smoking with risk
of pancreatic cancer among 37147 women and 45906 men followed up during 560666 person-years in the Swedish Mammography
Cohort and the Cohort of Swedish Men; 136 incident cases of pancreatic cancer were diagnosed. The multivariate rate ratio (RR) of
pancreatic cancer for obese women and men (BMI X30kg/m
2) was 1.81 (95% CI: 1.04–3.15) compared to those with a BMI of 20–
25kg/m
2. For a difference of 20cm (about two standard deviations) in waist circumference, the multivariate RRs were 1.32 (95% CI:
0.73–2.37) among women and 1.74 (95% CI: 1.00–3.01) among men. Pancreatic cancer risk was associated with history of diabetes
(multivariate RR: 1.88; 95% CI: 1.09–3.26) and cigarette smoking (multivariate RR for current compared with never smokers: 3.06;
95% CI: 1.99–4.72). Current smokers of X40 pack-years had a five-fold elevated risk compared with never smokers. Risk among past
smokers approached the RR for never smokers within 5–10 years following smoking cessation. Findings from this prospective study
support positive relationships of overall obesity, abdominal adiposity, diabetes and smoking with risk of pancreatic cancer.
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Cancer of the pancreas, the sixth leading cause of cancer death
in the European Union (Boyle and Ferlay, 2005), is a rapidly
fatal malignancy. Less than 5% of patients survive 5 years after
diagnosis (Sant et al, 2003). Primary prevention of pancreatic
cancer is therefore of particular importance. Unfortunately, the
etiology of pancreatic cancer remains largely elusive. Cigarette
smoking is the only generally accepted modifiable risk factor, but
explains only 25–29% of pancreatic cancer incidence (Silverman
et al, 1994; Fuchs et al, 1996).
Evidence from in vitro, animal and human studies indicates that
insulin, insulin resistance and abnormal glucose metabolism may
play a role in pancreatic cancer etiology (Fisher et al, 1996; Gapstur
et al, 2000; Schneider et al, 2001; Jee et al, 2005). Moreover,
epidemiological studies have suggested a relationship between
diabetes mellitus and increased risk of pancreatic cancer (Huxley
et al, 2005). Obesity, and specifically abdominal adiposity, has
been linked to metabolic abnormalities, including insulin resis-
tance, hyperinsulinemia, glucose intolerance and to the develop-
ment of diabetes mellitus (Kahn and Flier, 2000; IARC, 2002).
Thus, obesity may be a risk factor for pancreatic cancer. However,
epidemiological studies of body mass index (BMI), as a measure of
overall obesity, in relation to risk of pancreatic cancer have yielded
inconsistent results with a positive association observed in some,
but not all studies (Berrington de Gonzalez et al, 2003). To our
knowledge, no study has investigated the association between waist
circumference, as an estimate of abdominal adiposity, and risk of
pancreatic cancer.
In two prospective population-based cohorts of Swedish women
and men, we examined the relationships between overall obesity
(reflected by BMI) and abdominal adiposity (waist circumference)
and the risk of pancreatic cancer. In addition, we report findings
for diabetes, cigarette smoking and smoking cessation on
pancreatic cancer risk.
MATERIALS AND METHODS
Study population
Two population-based prospective cohort studies provided data
for the present analyses: the Swedish Mammography Cohort
(SMC) and the Cohort of Swedish Men (COSM). The SMC was
established between 1987 and 1990, when all women born between
1914 and 1948 and living in central Sweden (Va ¨stmanland and
Uppsala counties) received a mailed questionnaire that elicited
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yinformation on diet, weight, height and education; 66651 women
(74% of the source population) returned a completed question-
naire. In the autumn of 1997, an expanded questionnaire that
included data on various lifestyle factors and medical history was
mailed to women who were still alive and residing in the study
area; 39227 women (70%) completed the questionnaire. In the
autumn of 1997, 48850 men born between 1918 and 1952 and
residing in central Sweden (Va ¨stmanland and O ¨rebro counties)
were enrolled in the COSM by return of a mailed questionnaire
that was identical to the 1997 SMC questionnaire (except for some
sex-specific questions).
Eligible participants for the present study were women and men
who completed the 1997 questionnaire (information on cigarette
smoking and diabetes was first obtained in 1997). After excluding
participants with erroneous or missing national registration
number and those with a cancer diagnosis (except nonmelanoma
skin cancer) before baseline, a total of 37147 women and 45906
men were eligible for follow-up. The study was approved by the
Regional Ethical Review Board in Stockholm.
Assessment of exposures
In 1997, participants completed a self-administered questionnaire
that included information on demographic characteristics, weight,
height, waist circumference, cigarette smoking status and history,
alcohol consumption, dietary intake, physical activity and history
of diabetes mellitus; complementary information on diabetes for
subjects who were hospitalized was obtained from the Swedish
Inpatient Register. Pack-years were estimated from baseline
smoking history by multiplying the number of years of smoking
by the average number of packs of cigarettes smoked. We
estimated BMI from self-reported weight and height (kg/height
in m
2) as a measure of overall obesity. High validity has been
observed for self-reported height (r¼0.9) and weight (r¼0.9)
compared with actual measurement among Swedish women and
men (Kuskowska-Wolk et al, 1989). We used self-reported waist
circumference as an estimate of abdominal adiposity. We do not
have validity data for self-report of waist from the Swedish
population, but results from an UK population have indicated high
validity (r¼0.8) (Spencer et al, 2004).
Ascertainment of cases and follow-up
Incident cases of pancreatic cancer were identified by compu-
terised record linkage of the study population to the National
Swedish Cancer Register and the Regional Cancer Register
covering the study area, both of which have been estimated to be
nearly 100% complete (Mattsson and Wallgren, 1984). Pancreatic
cancer cases were defined as primary malignant neoplasm of the
exocrine pancreas [International Classification of Diseases, Ninth
Revision (ICD-9) code 157]. We excluded islet-cell carcinomas
(ICD-9 code 157.4) because the etiology of these tumors may be
different from that of the exocrine pancreas. Information on dates
of death and dates of moving out of the study area was obtained
from the Swedish Death and Population registries.
Statistical analysis
Person-years of follow-up for each participant were computed as
the time from baseline to the date of diagnosis of pancreatic
cancer, death from any cause, emigration, or until December 31,
2004. Participants were categorized into four groups with BMI
(kg/m
2) corresponding to o20.0, 20.0–24.9 (reference group),
25.0–29.9 and X30.0. Participants with a BMI below 15 or above
60kg/m
2 were excluded in the BMI analyses. For waist circumfer-
ence, we used quartiles based on the distribution among women
and men separately.
Cox proportional hazards models (Cox and Oakes, 1984) were
used to estimate rate ratios (RRs) with 95% confidence intervals
(CIs). Age (in months) and sex were controlled for as stratification
variables in the Cox model. In multivariate models, we included
education (less than high school, high-school graduate, or more
than high school), BMI (o20.0, 20.0–25.0, 25.0–29.9, or X30kg/m
2),
physical activity (four categories), history of diabetes (yes or no),
cigarette smoking (never, past o20 pack-years, past X20 pack-
years, current o20 pack-years, current 20–39 pack-years, or
current X40 pack-years) and alcohol consumption (quartiles).
Multivariate analyses of waist circumference were further con-
trolled for height (quartiles). Trends tests for BMI and waist
circumference were performed by scoring the categories and
entering the score as a continuous term in the regression model.
Statistical interaction between BMI and cigarette smoking in
relation to pancreatic cancer risk was tested using the likelihood
ratio test. We used the SAS statistical package (version 9.1; SAS
Institute, Inc., Cary, NC, USA) for all analyses. All statistical tests
are two-sided.
RESULTS
A total of 136 incident cases (61 females and 75 males) of
pancreatic cancer were diagnosed during 560666 person-years of
follow-up, yielding a crude incidence rate of 24.3 per 100000
person-years. The incidence rate was similar among women (24.1
per 100000 person-years) and men (24.4 per 100000 person-
years). The mean (7s.d.) age of the participants at baseline in 1997
was 62 (9.3) years for women and 60 (9.7) years for men. The mean
(7s.d.) age of the participants at time of diagnosis of pancreatic
cancer was 72 (8.5) years for female cases and 72 (8.0) years for
male cases. Table 1 presents the baseline characteristics by BMI.
The mean (7s.d.) baseline BMI was 25.0 (3.9)kg/m
2 among
women and 25.8 (3.4)kg/m
2 among men. In all, 34% percent of the
women and 46% of the men were overweight (BMI 25–29.9kg/m
2);
11% percent of the women and 10% of the men were obese
(BMI X30kg/m
2). Compared with women and men with a BMI of
20–25kg/m
2, obese women and men were less likely to have a
post-secondary education and to be current smokers, but were
more likely to have diabetes; they also exercised less and had
lower alcohol consumption. BMI was strongly correlated with
waist circumference (women, r¼0.76; men, r¼0.75). The
proportions of never, past and current smokers, respectively, at
baseline were 54, 27 and 19% among women and 36, 46 and 18%
among men.
We observed a positive association between BMI and risk of
pancreatic cancer (Table 2). After controlling for age and other
potential risk factors for pancreatic cancer, women and men with a
BMI of 30kg/m
2 or higher had an 81% increased risk compared
with those with a BMI of 20–25kg/m
2. When analysed as a
continuous variable, an increment of 1 BMI unit (kg/m
2) was
related to a 5% increased risk of pancreatic cancer among women
and men combined (RR: 1.05; 95% CI: 1.00–1.10), a 4% increased
risk among women (RR: 1.04; 95% CI: 0.97–11), and a 6%
increased risk among men (RR: 1.06; 95% CI: 0.99–1.14). The
findings for BMI did not change appreciably after excluding cases
that occurred within the first year of follow-up. Waist circumfer-
ence was also positively associated with risk of pancreatic cancer,
and similar to the observed association for BMI; the risk was
greater among men (Table 2). For a difference of 20cm
(approximately two standard deviations) in waist circumference,
the multivariate RRs were 1.32 (95% CI: 0.73–2.37) among women
and 1.74 (95% CI: 1.00–3.01) among men.
A history of diabetes was associated with a statistically
significant 1.9-fold elevated risk of pancreatic cancer (Table 2).
This association remained after early follow-up cancers (i.e., those
diagnosed within the first year) were excluded (RR: 1.97; 95%
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confined to men, but the number of diabetic women with
pancreatic cancer was small (n¼5).
Women and men who were current smokers at baseline had a
significantly higher risk of pancreatic cancer compared with never
smokers (Table 3). Past smoking was not related to a significantly
increased risk, although women who had smoked in the past had
a nonsignificant elevation in risk. Risk of pancreatic cancer
increased with increasing number of pack-years of smoking.
Current smokers of 40 or more pack-years had a fivefold elevated
risk of pancreatic cancer compared to never smokers. An
increment of 10 pack-years of smoking was associated with a
multivariate RR of 1.36 (95% CI: 1.15–1.61; P value for
trend¼0.0003).
We also assessed the association between smoking cessation and
risk of pancreatic cancer (Figure 1). Compared with current
smokers, the RR among past smokers diminished steeply and
approached the RR for never smokers within 5–10 years following
smoking cessation.
Figure 2 shows the RRs of pancreatic cancer according to cross-
classification of BMI and smoking status. High BMI and cigarette
smoking were independently associated with increased risk of
Table 1 Age-standardised characteristics among women and men according to categories of body mass index at baseline
Body mass index (kg/m
2)
Characteristics o20.0 20.0–24.9 25.0–29.9 X30.0
Women
Age in years, mean 62.6 61.0 62.6 62.1
Postsecondary education (%) 24.8 21.4 15.8 12.8
Current smokers (%) 30.8 20.7 17.1 14.8
Pack-years ever smoked (past or current), mean 16.2 14.4 15.3 16.5
Exercise (hours/week) 2.6 2.5 2.3 2.0
History of diabetes (%) 2.3 2.7 4.8 9.5
Waist circumference, mean (cm) 72.2 79.1 88.2 99.3
Alcohol consumption, mean (g/day) 4.1 4.2 3.6 2.7
Men
Age in years, mean 62.2 60.1 60.1 59.7
Postsecondary education (%) 23.4 19.9 14.5 11.1
Current smokers (%) 32.5 19.7 16.5 16.8
Pack-years ever smoked (past or current), mean 24.4 19.1 19.8 22.4
Exercise (hours/week) 2.4 2.7 2.5 2.2
History of diabetes (%) 3.8 4.2 6.2 12.8
Waist circumference, mean (cm) 82.5 90.2 98.9 110.9
Alcohol consumption, mean (g/day) 9.9 10.5 10.3 9.1
Table 2 Rate ratios (95% confidence intervals) of pancreatic according to body mass index, waist circumference, and diabetes
Women Men Woman and men
Cases
a Age-adjusted RR Multivariate RR
b Cases
a Age-adjusted RR Multivariate RR
b Multivariate RR
b,c
Body mass index (kg/m
2)
o20.0 3 0.94 (0.28–3.16) 0.76 (0.22–2.59) 2 1.46 (0.34–6.20) 1.54 (0.35–6.66) 0.96 (0.38–2.46)
20.0–24.9 24 1.00 (reference) 1.00 (reference) 26 1.00 (reference) 1.00 (reference) 1.00 (reference)
25.0–29.9 25 1.44 (0.82–2.54) 1.57 (0.87–2.81) 29 1.02 (0.60–1.73) 1.06 (0.62–1.82) 1.25 (0.84–1.86)
X30.0 7 1.32 (0.56–3.08) 1.48 (0.60–3.62) 12 1.99 (1.00–3.98) 2.08 (1.02–4.25) 1.81 (1.04–3.15)
P for trend 0.27 0.12 0.21 0.17 0.04
Waist circumference
d
Quartile 1 8 1.00 (reference) 1.00 (reference) 8 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 8 0.87 (0.32–2.33) 0.94 (0.34–2.58) 12 1.29 (0.52–3.16) 1.36 (0.55–3.36) 1.15 (0.59–2.25)
Quartile 3 18 1.45 (0.62–3.38) 1.77 (0.74–4.22) 16 1.36 (0.58–3.20) 1.48 (0.62–3.51) 1.59 (0.87–2.93)
Quartile 4 15 1.18 (0.49–2.84) 1.46 (0.58–3.66) 21 1.94 (0.85–4.40) 2.00 (0.85–4.66) 1.72 (0.93–3.20)
P for trend 0.46 0.23 0.10 0.10 0.05
History of diabetes
No 57 1.00 (reference) 1.00 (reference) 64 1.00 (reference) 1.00 (reference) 1.00 (reference)
Yes 5 1.42 (0.56–3.60) 1.31 (0.49–3.47) 11 2.13 (1.11–4.09) 2.32 (1.19–4.53) 1.88 (1.09–3.26)
aThe number of cases may not sum up to the total number of cases owing to missing data on BMI or waist circumference.
bMultivariate models were stratified by age in months
at baseline and were simultaneously adjusted for education (less than high school, high school graduate, and more than high school), physical activity (four categories), cigarette
smoking (never, past o20 pack-years, past X20 pack-years, current o20 pack-years, current 20–39 pack-years, or current X40 pack-years), and alcohol consumption
(quartiles). Analyses of body mass index were further adjusted for diabetes; analyses of waist circumference were further adjusted for diabetes and height (quartiles); analyses of
diabetes were further adjusted for body mass index.
cAlso adjusted for sex.
dCut points for quartiles of waist circumference (cm) for women were o76, 76–81, 82–89, and
X90; for men o90, 90–94, 95–101, and X102.
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between these variables (P for interaction¼0.74). Compared with
nonsmokers (never and past) with a BMI of less than 25kg/m
2,
current smokers with a BMI of 30kg/m
2 or more, had a
multivariate RR of 5.07 (CI: 1.93–13.30).
DISCUSSION
In this prospective analysis, we observed approximately a doubling
of the risk of pancreatic cancer for obese women and men (BMI
X30kg/m
2) compared with those with a normal weight (BMI
20–25kg/m
2). We also confirmed associations between history of
diabetes and cigarette smoking and increased risk of pancreatic
cancer. In addition, we found that smokers who had quit smoking
for 5–10 years had a risk of developing pancreatic cancer similar
to that of never smokers.
To our knowledge, this was the first study to evaluate the
relationship between waist circumference (reflecting abdominal
adiposity) and risk of pancreatic cancer. We found that waist
circumference was positively associated with pancreatic cancer
risk, particularly among men. A previous cohort study found that
women and men who reported ‘central’ weight gain had increased
relative risk of pancreatic cancer compared with women and men
who reported peripheral weight gain; the association was stronger
among men (Patel et al, 2005).
Previous studies of BMI and pancreatic cancer risk have
produced inconsistent results. A recent meta-analysis of 14 studies
Table 3 Rate ratios (95% confidence intervals) of pancreatic cancer according to cigarette smoking status and total number of pack-years of smoking
Women Men Woman and men
Cases Age-adjusted RR Multivariate RR
a Cases Age-adjusted RR Multivariate RR
a Multivariate RR
a,b
Smoking status
Never smoked 26 1.00 (reference) 1.00 (reference) 22 1.00 (reference) 1.00 (reference) 1.00 (reference)
Past smoker 13 1.48 (0.75–2.93) 1.39 (0.69–2.78) 32 1.10 (0.64–1.89) 1.00 (0.57–1.74) 1.16 (0.75–1.80)
Current smoker 22 3.44 (1.91–6.19) 3.81 (2.08–7.00) 21 2.52 (1.38–4.63) 2.47 (1.33–4.55) 3.06 (1.99–4.72)
Pack-years,
c past smokers
Never smoked 26 1.00 (reference) 1.00 (reference) 22 1.00 (reference) 1.00 (reference) 1.00 (reference)
o20 7 0.95 (0.41–2.22) 0.90 (0.38–2.12) 18 0.90 (0.48–1.69) 0.84 (0.44–1.58) 0.92 (0.56–1.53)
X20 6 4.36 (1.75–10.89) 4.15 (1.63–10.51) 14 1.52 (0.77–2.98) 1.33 (0.67–2.66) 1.91 (1.08–3.35)
Pack-years,
c current smokers
Never smoked 26 1.00 (reference) 1.00 (reference) 22 1.00 (reference) 1.00 (reference) 1.00 (reference)
o20 8 2.38 (1.06–5.34) 2.65 (1.16–6.05) 7 2.33 (0.98–5.53) 2.30 (0.97–5.50) 2.46 (1.35–4.49)
20–39 11 4.21 (2.02–8.78) 4.81 (2.27–10.18) 5 1.54 (0.58–4.13) 1.53 (0.57–4.11) 2.91 (1.62–5.25)
X40 3 7.71 (2.24–26.59) 6.90 (1.91–24.93) 9 4.23 (1.92–9.33) 4.05 (1.81–9.06) 5.13 (2.60–10.11)
aMultivariate models were stratified by age in months at baseline and were simultaneously adjusted for education (less than high school, high school graduate, and more than high
school), body mass index (o20.0, 20.0–24.9, 25.0–29.9, or X30kg/m
2), physical activity (four categories), history of diabetes (yes, no), and alcohol consumption (quartiles).
bAlso adjusted for sex.
cNumber of packs of cigarettes smoked per day (one pack contains 20 cigarettes) multiplied by the number of years of smoking.
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Figure 1 Multivariate rate ratios of pancreatic cancer in relation to time
since quitting of smoking among women and men. Multivariate models
were stratified by age in months at baseline and sex and were
simultaneously adjusted for education (less than high school, high school
graduate, or more than high school), body mass index (o20.0, 20.0–24.9,
25.0–29.9, or X30kg/m
2), physical activity (four categories), history of
diabetes (yes or no), and alcohol consumption (quartiles).
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Figure 2 Multivariate rate ratios of pancreatic cancer according to body
mass index (BMI) and cigarette smoking status among women and men.
Multivariate models were stratified by age in months at baseline and sex
and were simultaneously adjusted for education (less than high school, high
school graduate, or more than high school), physical activity (four
categories), history of diabetes (yes or no), and alcohol consumption
(quartiles). Nonsmoker include never and past smokers. *Statistically
significant.
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in risk among obese individuals compared with those with a
normal weight (RR: 1.19; 95% CI: 1.10–1.29 for BMI 30 vs
22kg/m
2) (Berrington de Gonzalez et al, 2003). The summary risk
estimate was higher when the authors excluded studies that did
not control for smoking; the estimate was also higher for cohort
than for case–control studies (Berrington de Gonzalez et al,
2003). Since that meta-analysis, two case–control studies based
on direct patient interviews (Pan et al, 2004; Fryzek et al, 2005)
and two cohort studies (Samanic et al, 2004; Patel et al, 2005)
have reported a statistically significant positive relation between
BMI and pancreatic cancer risk in both women and men or
only in men. Another cohort of elderly women observed no
increase in pancreatic cancer risk with greater BMI (Sinner et al,
2005).
In the present study, we observed a 1.9-fold higher risk of
pancreatic cancer among women and men with diabetes. A meta-
analysis of 17 case–control and 19 cohort or nested case–control
studies (Huxley et al, 2005) showed a 1.8-fold higher risk of
pancreatic cancer associated with a history of diabetes; the
magnitude of the positive association was greater among
individuals whose diabetes had been recently diagnosed.
A metabolic consequence of obesity, particularly the accumula-
tion of intra-abdominal fat, is the development of insulin
resistance, which leads to an increase in the secretion of insulin
from the pancreas (IARC, 2002). A role of hyperinsulinemia in
pancreatic pathogenesis might be through an increase in local
blood flow and cell division in the pancreas (Henderson et al,
1981). The exocrine pancreatic cells are exposed to very high
insulin concentrations through a portal circulation system from
the insulin-producing pancreatic islets (Williams and Goldfine,
1985). High concentrations of insulin are able to activate the
insulin-like growth factor I (IGF-I) receptor, and activation of
this receptor leads to growth-promoting effects (Le Roith, 1997).
Furthermore, excess insulin, through downregulation of the
insulin-like growth factor binding protein-1, could result in an
increase in the exposure to free IGF-I (Giovannucci, 2003). Both
insulin and IGF-I have been shown to promote growth in
pancreatic cell lines (Ohmura et al, 1990; Takeda and Escribano,
1991; Bergmann et al, 1995; Fisher et al, 1996).
This study has several strengths. The prospective design
precluded recall bias and the need to use next-of-kin respondents.
In addition, we had virtually complete follow-up as incident cases
of pancreatic cancer were ascertained by record linkage to the
Swedish Cancer Registry. Differential follow-up is therefore
unlikely to have affected our results. We were also able to control
for potential confounding by most known or possible risk factors
for pancreatic cancer. Because data regarding exposures were
collected before the diagnosis of pancreatic cancer, any mis-
classification would be nondifferential and would most likely
have weakened rather than exaggerated any true associations. A
limitation of this study is the self-reported information on
anthropometric measures, diabetes and cigarette smoking. Over-
weight and obese individuals tend to underestimate their body
size (weight, BMI, waist) to a greater extent than those who are
lean, and shorter individuals tend to overestimate their height
(Kuskowska-Wolk et al, 1989; Spencer et al, 2004). These biases
are likely to attenuate risk estimates of the relations between BMI
and waist circumference and risk of pancreatic cancer; thus the
associations may be even stronger in the absence of measurement
error. Another limitation of our study is the lack of information on
timing of diagnosis of diabetes.
In summary, results from this population-based prospective
study suggest that obesity may increase the risk for pancreatic
cancer. Findings from this study also provide further support for
associations of history of diabetes and cigarette smoking with
pancreatic cancer risk.
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